1,2,3,4-tetrahydroisoquinoline

estrogen receptor 1 ; Homo sapiens







5 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34610548 Development of novel tetrahydroisoquinoline-hydroxamate conjugates as potent dual SERDs/HDAC inhibitors for the treatment of breast cancer. 2021 Dec 15 3
2 28296398 Discovery of an Acrylic Acid Based Tetrahydroisoquinoline as an Orally Bioavailable Selective Estrogen Receptor Degrader for ERα+ Breast Cancer. 2017 Apr 13 1
3 18272256 Synthesis and preliminary biological evaluation of new carbon-11 labeled tetrahydroisoquinoline derivatives as SERM radioligands for PET imaging of ER expression in breast cancer. 2008 Oct 1
4 15686893 QSAR of estrogen receptor modulators: exploring selectivity requirements for ER(alpha) versus ER(beta) binding of tetrahydroisoquinoline derivatives using E-state and physicochemical parameters. 2005 Feb 15 2
5 12825935 Estrogen receptor modulators: identification and structure-activity relationships of potent ERalpha-selective tetrahydroisoquinoline ligands. 2003 Jul 3 1